Neural Tube Defects
|
0.400 |
GeneticVariation
|
group |
BEFREE |
Analysis of the MTHFD1 promoter and risk of neural tube defects.
|
19130090 |
2009 |
Neural Tube Defects
|
0.400 |
GeneticVariation
|
group |
LHGDN |
In summary, our results indicate that heterozygosity and homozygosity for the MTHFD1 1958G > A polymorphism are genetic determinants of NTD risk in the cases examined.
|
16315005 |
2006 |
Neural Tube Defects
|
0.400 |
GeneticVariation
|
group |
BEFREE |
We have established that the MTHFD1 1958G>A polymorphism has a significant role in influencing a mother's risk of having an NTD-affected pregnancy in the Irish population.
|
16552426 |
2006 |
Neural Tube Defects
|
0.400 |
GeneticVariation
|
group |
BEFREE |
In summary, our results indicate that heterozygosity and homozygosity for the MTHFD1 1958G > A polymorphism are genetic determinants of NTD risk in the cases examined.
|
16315005 |
2006 |
Neural Tube Defects
|
0.400 |
Biomarker
|
group |
CTD_human |
We have established that the MTHFD1 1958G>A polymorphism has a significant role in influencing a mother's risk of having an NTD-affected pregnancy in the Irish population.
|
16552426 |
2006 |
Neural Tube Defects
|
0.400 |
GeneticVariation
|
group |
BEFREE |
We conclude that genetic variation in the MTHFD1 gene is associated with an increase in the genetically determined risk that a woman will bear a child with NTD and that the gene may be associated with decreased embryo survival.
|
12384833 |
2002 |
Neural Tube Defects
|
0.400 |
Biomarker
|
group |
CTD_human |
We conclude that genetic variation in the MTHFD1 gene is associated with an increase in the genetically determined risk that a woman will bear a child with NTD and that the gene may be associated with decreased embryo survival.
|
12384833 |
2002 |
Neural Tube Defects
|
0.400 |
GeneticVariation
|
group |
BEFREE |
A selected number of SBA patients was additionally tested for specific mutations in MTHFD, FRalpha, and PAX1 already shown to be related to NTD.
|
11320527 |
2001 |
Neural Tube Defects
|
0.400 |
Biomarker
|
group |
BEFREE |
Our results so far provide no evidence for a major role of the methylenetetrahydrofolate-dehydrogenase (MTHFD) gene in NTD etiology.
|
9611072 |
1998 |
Schizophrenia
|
0.320 |
GeneticVariation
|
disease |
BEFREE |
This region contains 15 genes, including spectrin beta (SPTB), encoding a cytoskeletal protein previously associated with spherocytosis, methylenetetrahydrofolate dehydrogenase 1 (MTHFD1), a folate metabolizing enzyme previously associated with bipoloar disorder and schizophrenia, pleckstrin homology domain-containing family G member 3 (PLEKHG3), a guanide nucleotide exchange enriched in the brain, and churchill domain containing protein 1 (CHURC1), homologs of which regulate neuronal development in model organisms.
|
21360829 |
2011 |
Schizophrenia
|
0.320 |
GeneticVariation
|
disease |
BEFREE |
MTHFD 1958G>A and MTR 2756A>G polymorphisms are associated with bipolar disorder and schizophrenia.
|
17417062 |
2007 |
Schizophrenia
|
0.320 |
Biomarker
|
disease |
PSYGENET |
Therefore, we examined the prevalence of 1958G>A polymorphism of MTHFD1 gene, encoding trifunctional folate enzyme 5,10-methylenetetrahydrofolate dehydrogenase, 5,10-methenyltetrahydrofolate cyclohydrolase and 10-formyltetrahydrofolate synthetase (MTHFD1), and 2756A>G variant of methionine synthase (MTR) gene in patients with BD (n=200), schizophrenia (n=200) and in controls (n=300).
|
17417062 |
2007 |
Schizophrenia
|
0.320 |
GeneticVariation
|
disease |
LHGDN |
Therefore, we examined the prevalence of 1958G>A polymorphism of MTHFD1 gene, encoding trifunctional folate enzyme 5,10-methylenetetrahydrofolate dehydrogenase, 5,10-methenyltetrahydrofolate cyclohydrolase and 10-formyltetrahydrofolate synthetase (MTHFD1), and 2756A>G variant of methionine synthase (MTR) gene in patients with BD (n=200), schizophrenia (n=200) and in controls (n=300).
|
17417062 |
2007 |
Bipolar Disorder
|
0.310 |
Biomarker
|
disease |
PSYGENET |
Therefore, we examined the prevalence of 1958G>A polymorphism of MTHFD1 gene, encoding trifunctional folate enzyme 5,10-methylenetetrahydrofolate dehydrogenase, 5,10-methenyltetrahydrofolate cyclohydrolase and 10-formyltetrahydrofolate synthetase (MTHFD1), and 2756A>G variant of methionine synthase (MTR) gene in patients with BD (n=200), schizophrenia (n=200) and in controls (n=300).
|
17417062 |
2007 |
Bipolar Disorder
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
Therefore, we examined the prevalence of 1958G>A polymorphism of MTHFD1 gene, encoding trifunctional folate enzyme 5,10-methylenetetrahydrofolate dehydrogenase, 5,10-methenyltetrahydrofolate cyclohydrolase and 10-formyltetrahydrofolate synthetase (MTHFD1), and 2756A>G variant of methionine synthase (MTR) gene in patients with BD (n=200), schizophrenia (n=200) and in controls (n=300).
|
17417062 |
2007 |
Diastematomyelia
|
0.300 |
Biomarker
|
disease |
CTD_human |
Confirmation of the R653Q polymorphism of the trifunctional C1-synthase enzyme as a maternal risk for neural tube defects in the Irish population.
|
16552426 |
2006 |
Neurenteric Cyst
|
0.300 |
Biomarker
|
disease |
CTD_human |
Confirmation of the R653Q polymorphism of the trifunctional C1-synthase enzyme as a maternal risk for neural tube defects in the Irish population.
|
16552426 |
2006 |
Tethered Cord Syndrome
|
0.300 |
Biomarker
|
disease |
CTD_human |
Confirmation of the R653Q polymorphism of the trifunctional C1-synthase enzyme as a maternal risk for neural tube defects in the Irish population.
|
16552426 |
2006 |
Iniencephaly
|
0.300 |
Biomarker
|
disease |
CTD_human |
Confirmation of the R653Q polymorphism of the trifunctional C1-synthase enzyme as a maternal risk for neural tube defects in the Irish population.
|
16552426 |
2006 |
Craniorachischisis
|
0.300 |
Biomarker
|
disease |
CTD_human |
Confirmation of the R653Q polymorphism of the trifunctional C1-synthase enzyme as a maternal risk for neural tube defects in the Irish population.
|
16552426 |
2006 |
Exencephaly
|
0.300 |
Biomarker
|
disease |
CTD_human |
Confirmation of the R653Q polymorphism of the trifunctional C1-synthase enzyme as a maternal risk for neural tube defects in the Irish population.
|
16552426 |
2006 |
Spinal Cord Myelodysplasia
|
0.300 |
Biomarker
|
disease |
CTD_human |
Confirmation of the R653Q polymorphism of the trifunctional C1-synthase enzyme as a maternal risk for neural tube defects in the Irish population.
|
16552426 |
2006 |
Acrania
|
0.300 |
Biomarker
|
disease |
CTD_human |
Confirmation of the R653Q polymorphism of the trifunctional C1-synthase enzyme as a maternal risk for neural tube defects in the Irish population.
|
16552426 |
2006 |
Spina bifida aperta of cervical spine
|
0.300 |
SusceptibilityMutation
|
disease |
ORPHANET |
Confirmation of the R653Q polymorphism of the trifunctional C1-synthase enzyme as a maternal risk for neural tube defects in the Irish population.
|
16552426 |
2006 |
Abruptio Placentae
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
We conclude that women who are 'QQ' homozygote for the MTHFD1 1258G --> A (R653Q) polymorphism are almost three times more likely to develop severe abruptio placentae during their pregnancy than women who are 'RQ' or 'RR.'
|
15633187 |
2005 |